Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
- 期刊名称Clinical Ophthalmology
- 作者Loukovaara, Sirpa; Tuuminen, Raimo
- 电子ISSN1177-5483
- 文件大小379.63KB
- 发表时间2016-05
- DOI10.2147/opth.s105686
Linagliptin: from bench to bedsideDoupis, John · Drug Design, Development and Therapy · 2014
in miceBastaki, Salim; Abdulrazzaq, Yousef; Shafiullah, Mohamed; Więcek, Małgorzata; Kieć-Kononowicz, Katarzyna; Sadek, Bassem · Drug Design, Development and Therapy · 2018
ArrayCan, Behzat; Atilgan, Remzi; Pala, Sehmus; Kuloğlu, Tuncay; Kiray, Sule; Ilhan, Nevin · Drug Design, Development and Therapy · 2018
Neuroprotective therapies for glaucomaSong, Wei; Huang, Ping; Zhang, Chun · Drug Design, Development and Therapy · 2015
Inhaled treprostinil: a therapeutic reviewChannick, Richard; Voswinckel, ; Rubin, Lewis; Vultaggio, · Drug Design, Development and Therapy · 2012
The renoprotective effects of sulodexideVogt, Liffert; Olde Engberink, Rik · Drug Design, Development and Therapy · 2016
Antiviral therapy: a perspectiveShahidi Bonjar, Amir Hashem · Drug Design, Development and Therapy · 2016
CorrigendumMotlekar, Nelson · Drug Design, Development and Therapy · 2010